May 02, 2026
Long-term noninvasive ventilation (NIV) has become a cornerstone therapy for patients with chronic respiratory insufficiency and sleep-related breathing disorders such as obesity-hypoventilation syndrome and chronic hypercapnic COPD. NIV provides ventilatory support without invasive airway placement, offering symptom relief, improved gas exchange and enhanced quality of life. In some cases, it offers reduced mortality and hospital readmissions compared with conventional care.
Its use has expanded not only in sleep medicine but also across pulmonary and critical care practice, particularly as a bridge from acute care hospitalization to long-term home support. "While the physiological benefits of NIV are well established, the transition from hospital to home remains a vulnerable point in the care continuum, with patient outcomes often limited by system-level barriers rather than by the efficacy of the therapy," says Bernardo J. Selim, M.D., a pulmonologist, sleep medicine and critical care specialist at Mayo Clinic in Rochester, Minnesota.
Patients discharged on long-term NIV represent a medically fragile population. Without robust, standardized pathways to support discharge and outpatient follow-up, many face challenges with adherence, equipment access and coordinated care — ultimately compromising potential benefits. "This transition phase matters because it influences long-term outcomes, healthcare utilization, and overall patient and caregiver experience," Dr. Selim states.
Summary and major findings
A recent Mayo Clinic narrative review published in Sleep Medicine Clinics synthesizes existing literature and expert perspectives on how to optimize transitions of care for patients on long-term NIV.
Major findings include:
- Physiological and quality-of-life benefits of NIV: Continued support with NIV after discharge can normalize arterial blood gases, reduce symptoms of chronic hypoventilation, improve overall quality of life, and potentially decrease readmissions and mortality in selected patients.
- System barriers: Reimbursement limitations, lack of standardized discharge pathways and inconsistent outpatient support structures are major barriers that may blunt the full impact of NIV after discharge.
- Importance of structured transitions: Effective transitions require clear protocols, interdisciplinary coordination, patient and caregiver education, and early planning, not simply prescription of a ventilator but integration of support systems before, during and after hospital discharge.
Interpretation
"The review's central interpretation is that while NIV is beneficial physiologically, its real-world effectiveness is heavily dependent on how well patients transition from the controlled environment of the hospital to the more variable home setting," Dr. Selim says. Poorly coordinated transitions, including delayed equipment provision, insufficient caregiver training, and lack of systematic follow-up can negate the potential benefits of NIV and leave patients vulnerable to readmission or therapy discontinuation.
Relevance to current practice in pulmonary and critical care medicine
For clinicians in pulmonary and critical care medicine, this review underscores the importance of treating NIV not just as a device prescription, but as part of a broader, multidisciplinary care plan. In everyday practice, this means:
- Planning transitions at the time of NIV initiation, anticipating equipment needs, insurance authorization timelines and outpatient support services.
- Engaging respiratory therapists, case managers, sleep specialists and home care providers early to ensure continuity.
- Providing structured education to patients and caregivers about mask interfaces, alarm systems, troubleshooting and symptom monitoring.
- Scheduling timely outpatient follow-up (within days to weeks of discharge) to review adherence data, comfort issues and physiological responses.
In essence, pulmonary and critical care teams should view NIV transitions as an extension of acute care management, requiring the same attention to detail as ventilator weaning protocols, discharge planning and chronic disease management paradigms.
Clinic care points
- Early identification and diagnosis: Promptly recognize sleep-related hypoventilation disorders such as obesity-hypoventilation syndrome (OHS), as they are often misdiagnosed, especially in hospitalized patients presenting with hypercapnic respiratory failure.
- Initiate appropriate NIV therapy before discharge: Follow guidelines by starting noninvasive ventilation for eligible inpatients with respiratory failure and suspected OHS prior to their discharge to optimize postdischarge outcomes.
- Comprehensive patient and caregiver education: Ensure patients and caregivers receive thorough training in NIV device operation, troubleshooting and maintenance, with attention to those with physical or learning disabilities.
- Individualized device selection and settings: Carefully select NIV modes and settings tailored to the patient's clinical needs, to facilitate comfort, adherence and therapeutic efficacy at home.
- Establish a structured outpatient follow-up plan: Arrange coordinated follow-up care, including monitoring arterial blood gases, assessing symptoms and evaluating health-related quality of life to reduce hospital readmissions and mortality.
Key takeaways
- Benefit is not automatic: The physiological advantages of NIV will not be reached unless discharge transitions and outpatient support are systematically addressed.
- Coordination matters: A standardized discharge pathway can improve continuity of care and reduce variability in outcomes.
- Education is critical: Empowering patients and caregivers with practical training enhances adherence and comfort.
- Multidisciplinary approach: Integrating sleep medicine, pulmonary, respiratory therapy and home care resources maximizes the probability of success.
For more information
Rodriguez FF et al. From inpatient to home: Optimizing transitions of care for patients on long-term noninvasive ventilation. Sleep Medicine Clinics. 2025;20:467.
Refer a patient to Mayo Clinic.